A Study of of MORAb-004 in Subjects With Solid Tumors
NCT00847054
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
80
Enrollment
INDUSTRY
Sponsor class
Conditions
Solid Tumor
Interventions
DRUG:
MORAb-004 (monoclonal antibody to TEM1)
Sponsor
Morphotek